Credits: Canva
Is your teenager skipping breakfast? Why is that happening and what can you do? As per the data from the Centers for Disease Control and Prevention (CDC), which surveyed adolescent health and well-being found that 1 in 4 students in high school ate breakfast, which means 3 in 4 high school students are not eating their breakfast. This data is as per the 2023 survey.
The report describes a 10-year long trend and also recent changes among the two years. The study delved deeper into adolescents' dietary, physical activity and sleep behaviors. The study is also based on a national youth risk behavior survey of a representative sample of students from grade nine to 12.
The study found that while high school students drank slightly less soda and sports drinks and consumed more water, other healthy eating habits declined. In 2023, only 27% of students ate breakfast every day in the past week. The numbers were even lower for female students, with just 22% eating breakfast daily, compared to 32% of male students. Boys were also more likely to eat fruits and vegetables daily and drink water at least three times a day. Poor mental health and lack of physical activity have also been linked to skipping breakfast.
The other findings included a survey across 10-year period, where a decrease in the percentage of students eating fruits from 65% to 55%, eating vegetables, from 61% to 58%, and having breakfast daily from 38% to 27% was noted.
However, there was a positive trend among this, which was in children drinking plain water at least three times a day, which increased from 49% to 54% from when the survey began in 2015.. There were fewer students who also said that they drank soda in 2023 than in 2013. On an average, in 2013, around 22% students avoided soda, whereas in 2023, 31% students avoided it.
The report also emphasized that a healthy diet, along with daily physical activity and sufficient sleep further contributes to a healthy lifestyle. “The 10-year trends from 2013 to 2023 also show a decline in healthy dietary, physical activity, and sleep behaviors,” the survey reported.
While there is no one straightforward answer to it, psychologists and those who study children, believe that for many high school going kids, it is the easiest time to skip a meal. This is because they are caught between rushing to school, or not just that hungry in the morning. So for them, to sit down to have a breakfast may seem hassle and something they would have to take time out from their busy schedule. They at this age also prioritize their extra-curricular activities.
There has also been a shift in their circadian rhythm, and most teens cannot fall asleep before 11 pm, or even at midnight. Which means they wake up tired and struggle to do things right in the morning, which is why they choose to skip breakfast or give extra minutes to any other activities.
There is of course another, more popular reason, to lose weight. While experts and studies, like the one published in the Journal of Nutrition that found skipping breakfast leads to higher levels of hunger hormones, the students still feel the need to do this. However, it could lead to a slow metabolism, prompt the body to conserve energy and burn fewer calories, weight gain and deprive yo off the essential nutrients like calcium, iron, and vitamin D.
Without a morning breakfast, your blood sugar might drop too, which can increase irritability and stress, along with including the risk of depression in teenage.
Credit: AI
The human brain has always been considered to be a single organ. But according to Stanford Medicine researchers, the brain's growth history indicates that it originates from two different populations of early cells that follow separate developmental paths.
The findings, published in Nature Neuroscience, suggest that the front and back parts of the brain develop from different types of progenitor cells, questioning the long-believed idea that the entire brain originates from one common cell.
An important point to note is that this does not mean that humans have two completely separate brains. The two developmental systems ultimately fuse together and function as one brain.
During early development, cells called progenitor cells enable the production of specialised brain cells, including neurons. Researchers found that the cells that form the forebrain and midbrain follow a different developmental pathway from those that form the hindbrain, which includes the brainstem.
The forebrain is involved in neurological functions like language, consciousness and higher-level thinking. The hindbrain contains structures that control essential functions including breathing, heartbeat, sleep and swallowing.
Kyle Loh, associate professor of developmental biology at Stanford Medicine and senior author, said, “We’ve shown for the first time that the front of the brain arises from a totally different progenitor cell than the back of the brain.”
He added, “Our discovery means that we can now grow neurons from the back of the brain, the hindbrain, in a petri dish and study their functions.”
Also read: Is Controlling BP Enough After a Brain Bleed? Doctors Explain How to Prevent Another Stroke
Scientists have been able to grow several types of human brain cells in the laboratory, but creating hindbrain neurons has been challenging.
The new findings give some clarity about why some previous approaches were unsuccessful. Researchers were attempting to transform forebrain or midbrain progenitor cells into hindbrain cells, but the Stanford team found that these cells are fundamentally different from the beginning of development.
Jokhai, one of the researchers involved in the study, explained, “Previous attempts to make hindbrain neurons likely tried to coax forebrain and midbrain progenitors into hindbrain cells, which our study shows is not possible.”
He added, “In stem cell biology, people are always fixated with creating the end cell type, like the neuron. But it’s important to begin at the earliest stages of embryonic development.”
The discovery could have various practical implications for neurological research. The hindbrain and brainstem contain neurons involved in breathing, swallowing and movement, meaning researchers need reliable human cells to study diseases that damage these systems.
Stanford scientists say the new findings allowed them to understand and generate functional human hindbrain neurons in the laboratory. This could provide new models for studying conditions like amyotrophic lateral sclerosis (ALS) and spinal muscular atrophy (SMA).
Instead of studying these diseases only in animals or using cells that do not accurately represent the affected brain region, researchers may now be able to grow relevant human neurons and investigate how they develop, malfunction and respond to different treatments.
The finding could therefore change not just how scientists understand the human brain's anatomy, but how they understand its origins and how they recreate different brain regions in the laboratory.
Credit: iStock
As artificial intelligence (AI) rapidly reshapes health research and clinical care, Anthropic and medical knowledge platform OpenEvidence have announced a collaboration to provide AI-powered clinical decision support to healthcare providers in dozens of low- and middle-income countries.
OpenEvidence answers doctors’ clinical questions using peer-reviewed research and treatment guidelines. The platform, already free to clinicians in the US and Europe, will now be extended to providers in countries where access to medical literature, specialist expertise and continuing education may be limited.
The initiative is being rolled out in about 100 countries, including Uganda, Angola, Sudan, Haiti and Mongolia, according to a list provided by OpenEvidence.
“Access to medical knowledge shouldn’t depend on geography,” OpenEvidence founder Daniel Nadler said.
Also read: Anthropic Says Claude Blocked Bird Flu, Chikungunya Research: How AI Could Enable Biological Misuse
Rajeev Jayadevan, former president of IMA Cochin and convener of the Research Cell, Kerala, told HealthandMe that doctors in Western countries already have access to OpenEvidence, which has also been incorporated into electronic medical records at major US hospitals.
He said the platform could help doctors quickly access medical evidence at the point of care.
“The advantage is that the doctor will have instant access to relevant research papers published in multiple journals, all at once, while asking a specific question about a patient while at the bedside,” Dr Rajeev said.
He called it “a major time-saving step for the busy clinician, who may not have the time to go to the library, sit down with medical journals or textbooks, or even do internet-based searches to look for relevant papers”.
Dr Rajeev also said wider access to medical information could help reduce inequalities in healthcare.
“Medical information that directly helps patients must be available to the doctor free of charge,” he said.
However, AI-based clinical tools also have limitations, particularly when used across different healthcare systems.
“Potential disadvantages include the need for doctors to be trained in digital health literacy and the fact that the answer provided by AI algorithms heavily depends on what the doctor asked for, and in what format,” Dr Rajeev said.
“Some of these issues can be ironed out by using templates, so that important information or keywords are not missed by the doctor who enters the query. Other risks include relying on data from other countries and treatment options that are unavailable or expensive for the local community,” he added.
The expansion of AI in healthcare comes as the WHO has separately called for stronger ethics oversight of AI-related health research.
In a report published this week, WHO warned that rapid advances in AI are creating challenges around privacy, bias, fairness, transparency and accountability. It said existing research ethics systems may need additional expertise to assess risks associated with AI and large datasets.
Dr Rajeev said AI-driven research, particularly when it involves large datasets crossing national borders, may require ethics committees to include experts in computer science, data ethics and bioinformatics.
“Ethics Committees by themselves will need to be upgraded to incorporate computer scientists, data ethicists, and bioinformaticians.”
WHO also said oversight should extend beyond ethics committees to researchers, funders, scientific journals, data governance bodies, professional societies and regulators.
For low- and middle-income countries, clinical AI could help bridge gaps in access to medical literature and specialist knowledge. At the same time, WHO has highlighted the need for local capacity and safeguards to ensure that AI systems developed largely in higher-income settings are appropriate for different healthcare systems and do not introduce new inequities.
Credit: AI
Postmenopausal bleeding is one of the key warning signs that needs medical intervention as it can be an indicator of endometrial, or womb, cancer. But most women who develop postmenopausal bleeding do not have cancer but still are required undergo several invasive tests to get a clean bill of health.
According to a new study published in The Lancet Obstetrics, Gynaecology & Women’s Health, cells from urine and vaginal fluid could help identify women who need further investigation and reduce the need for unnecessary and uncomfortable invasive procedures. However, the test is not yet accurate enough to replace biopsies or other standard tests these types of cancers.
Doctors usually recommend women with postmenopausal bleeding to undergo transvaginal ultrasound, endometrial biopsy and hysteroscopy.
These procedures can be uncomfortable, painful and costly, and some women may need repeat these tests. In the study, only 5.3% of women had endometrial cancer, despite all of them being referred for these tests due to postmenopausal bleeding.
The researchers said that cells shed by an endometrial tumour can travel into the lower genital tract and could be collected through vaginal fluid or urine. Previous research has already indicated that cancer cells could be detected in these samples.
The DETECT study was designed to determine how accurately this approach could detect cancer.
Also read: Endometriosis Can Take Years To Diagnose But This AI Tool Can Identify Its Signs In 18 Milliseconds
The study is based on 1,864 women with postmenopausal bleeding from seven hospitals in northwest England between September 2018 and March 2021.
The participants gave their urine and vaginal fluid samples before their routine cancer investigations. Specialist cytopathologists, who were not aware of the women's cancer diagnoses, examined the samples for malignant cancerous cells.
The results were then compared to the women's clinical diagnoses and, where available, tissue histopathology. Among them, 99 had endometrial cancer and 16 had other pelvic cancers, including cervical, ovarian, bladder and colorectal cancers. The test also detected about 8 in 10 womb cancers
When urine and vaginal cytology were combined, the test detected 80.8% of endometrial cancers and correctly identified 92.6% of women who did not have the disease. Its negative predictive value was 98.8%.
In this particular study population, that means a woman with a negative combined result was highly unlikely to have endometrial cancer. But the test was not equally effective at detecting every type of cancer.
It detected 95.8% of high-grade cancers and 96.4% of stage 2 or more advanced cancers. It was more likely to miss low-grade, early-stage tumours. According to the researchers, the urine and vaginal fluid samples may miss early-stage tumours as they may shed fewer cancer cells. The sensitivity of the test was lower than that of transvaginal ultrasound and endometrial biopsy when sufficient tissue was obtained.
Also read: Urine Leakage When You Cough, Sneeze Or Exercise? It Could Be Pelvic Floor Dysfunction, Say Experts
The study does not suggest that this test could replace conventional methods of diagnosis. It is merely an effective triage tool that could help screen patients and help healthcare providers decide who should actually get invasive tests done.
In the study, 99.1% of women underwent an attempted transvaginal ultrasound, 61.1% underwent an attempted endometrial biopsy and 48.2% underwent hysteroscopy. The failure rate was 25.7% for endometrial biopsy and 17.8% for hysteroscopy, with cervical stenosis and intolerable pain among reported reasons.
The test also produced false positives. Its positive predictive value for endometrial cancer was 38.1%, meaning a positive result would still require further investigation.
The researchers say further studies will establish how the test performs in standard healthcare systems, different populations, and other relevant settings. They also note that highly trained specialist cytopathologists interpreted the samples and helped provide diagnoses, so it remains uncertain whether the same accuracy can be achieved elsewhere.
Another interesting finding from the study is that among 10 women whose initial cytology missed cancer and who underwent repeat sampling, four tested positive on repeat testing, suggesting repeated sampling could improve detection.
The researchers also propose exploring artificial intelligence and image-recognition technology to supplement cytological analysis.
© $2026 Times Horizon Private Limited